The Rising Cost and Impact of Diabetes
The diabetes epidemic, particularly type 2 diabetes which affects about 95% of Americans living with the disease, is not only a significant health concern but also an enormous financial burden on the American healthcare system. Sen. Bernie Sanders led a hearing to scrutinize the role of the food and drug industries in the escalating cost of the disease, which accounted for nearly $413 billion last year alone, a staggering increase of 27% over the last six years.
The Food Industry’s Role in Diabetes and Obesity
Sanders’ hearing drew significant attention to the role of large corporations in the food and beverage industry in contributing to America’s diabetes and obesity epidemics. Sanders argues that these corporations knowingly entice children to consume unhealthy foods, subsequently increasing their risk of developing type 2 diabetes and obesity. One of the suggestions put forward during the hearing was the potential banning of junk food advertisements aimed at children, a move seen as a direct combat strategy against the escalating health crises.
The Pharmaceutical Industry and the High Cost of Diabetes Drugs
The pharmaceutical industry was not exempt from the hearing’s scrutiny. Sanders warned of the potential impact of new weight loss drugs on health care spending, with the potential to exponentially increase costs. The hearing also highlighted the role of pharmaceutical companies in the rising costs of insulin, a lifesaving medicine for diabetes patients. Sanders and other committee members underscored the need for legislation to lower drug prices and improve access to affordable healthcare for diabetes patients.
Proposed Solutions and Moving Forward
Among the solutions suggested during the hearing, the urgent need for more federally funded research into obesity was highlighted. Expert witnesses emphasized the necessity for nutritious food to be more competitive with unhealthy products and urged Congress to take decisive action on drug prices. There were calls to hold the food industry accountable and enact legislation to support diabetes research and prevent the disease.
Throughout the hearing, it was evident that both Senators Bernie Sanders and Bill Cassidy saw this issue as a priority for the Senate HELP committee moving forward. The focus on the food and drug industries in contributing to the diabetes epidemic and its associated costs was a clear indication of the urgency and importance of addressing this escalating health crisis.
Credit: Source link